Cardiovascular endocrinology & metabolism : theory and practice of cardiometabolic medicine

著者

書誌事項

Cardiovascular endocrinology & metabolism : theory and practice of cardiometabolic medicine

edited by Andrew J. Krentz, Robert J. Chilton

Academic Press, c2023

  • : pbk.

タイトル別名

Cardiovascular endocrinology and metabolism : theory and practice of cardiometabolic medicine

大学図書館所蔵 件 / 全1件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine discusses the close intersection between metabolic disorders and cardiovascular disease, covering the basic science and pathophysiology of disease and the latest research in pharmacological approaches and translational therapeutic options. This book is a valuable resource for the vascular and endocrinology clinical and research communities in need of knowledge and potential outcomes. The global increase in the prevalence of cardiometabolic disorders, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, is bringing endocrinologists and cardiologists together in a shared clinical experience.

目次

Part 1. Basic science and pathophysiology 1. Obesity and insulin resistance 2. Diabetes and macrovascular disease: epidemiology and cardiovascular risk assessment 3. Hypertension 4. Lipid metabolism: role in atherogenesis 5. Renal disease and cardiorenal interactions 6. NAFLD/NASH and cardiovascular risk 7. Heart failure 8. Prothrombosis: association with cardiometabolic disease 9. Inflammation, metabolism and cardiovascular disease 10. Classic endocrine disorders: association with vascular disease Part 2. Clinical evaluation, lifestyle measures and therapeutic options 11. Non-pharmacological strategies in the prevention and management of cardiometabolic disease 12. Obesity: pharmacological approaches to prevention and management 13. Diabetes: evolution of multifactorial vascular risk reduction 14. Diabetes CVOTS: design, interpretation and future directions 15. Novel glucose-lowering drugs: a new era of cardioprotection and renoprotection 16: Hypertension: pharmacological and surgical management 17. PCSK-9 inhibitors and other novel lipid-modifying drugs 18. Recent therapeutic developments in heart failure 19. Antiplatelet agents 20. Progress in anticoagulant therapy 21. Invasive treatment of atherosclerotic cardiovascular disease: today and tomorrow 22. Cardiometabolic medicine in practice: role of cardiologists vs endocrinologists and the need for a new clinical specialty

「Nielsen BookData」 より

詳細情報

ページトップへ